AFA
PFE icon

Atlanta Financial Associates’s Pfizer PFE Stock Holding History

Atlanta Financial Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$225K Hold
6,124
– – 0.11% 71
2020
Q4 		$225K Sell
6,124
-317
-5% -$11.6K 0.11% 70
2020
Q3 		$224K Buy
+6,441
New +$226K 0.12% 62

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Atlanta Financial Associates's PFE Position: Q1 2021 in Review

Atlanta Financial Associates held its Pfizer (PFE) position steady in Q1 2021 at 6,124 shares worth $225K. The position accounts for 0.11% of the portfolio, ranked #71.

Atlanta Financial Associates first reported a position in PFE in Q3 2020 and has held it in 3 quarters since. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Atlanta Financial Associates held 6,124 shares of Pfizer worth $225K as of Q1 2021.
  • Atlanta Financial Associates left its Pfizer share count unchanged in Q1 2021.
  • Pfizer made up 0.11% of Atlanta Financial Associates's portfolio in Q1 2021, its #71 holding.
  • Atlanta Financial Associates first reported a position in Pfizer in Q3 2020 and has held it in 3 quarters since.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Atlanta Financial Associates's 13F filing for Q1 2021, filed 19 May 2021.